• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Voyager Acquisition Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    3/18/26 4:05:14 PM ET
    $VACH
    Get the next $VACH alert in real time by email
    false 0002006815 0002006815 2026-03-12 2026-03-12 0002006815 vachu:UnitsEachConsistingOfOneClassOrdinaryShareAndOneHalfOfOneRedeemableWarrantMember 2026-03-12 2026-03-12 0002006815 vachu:ClassOrdinarySharesParValue0.0001PerShareMember 2026-03-12 2026-03-12 0002006815 vachu:WarrantsEachWholeWarrantEntitlingtTheHolderThereofToPurchaseOneClassAOrdinaryShareAtAPriceOf1150PerShareMember 2026-03-12 2026-03-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): March 12, 2026

     

     

     Voyager Acquisition Corp./Cayman Islands

    VOYAGER ACQUISITION CORP.

    (Exact name of registrant as specified in its charter)

     

     

     

    Cayman Islands   001-42211   00-0000000N/A
    (State or other jurisdiction
    of Incorporation)
      (Commission
    File No.)
      (IRS Employer
    Identification No.)

     

    131 Concord Street, Brooklyn, NY 11201

    (Address of principal executive offices and Zip Code)

     

     

     

    Registrant’s telephone number, including area code: (347) 720-2907

     

     

     

    Not applicable

    (Former name or former address, if changed since last report.)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Units, each consisting of one Class A ordinary share and one half of one redeemable warrant   VACHU   The Nasdaq Stock Market LLC
    Class A ordinary shares, par value $0.0001 per share   VACH   The Nasdaq Stock Market LLC
    Warrants, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, exercisable 30 days after the completion of our initial business combination and will expire five years after the completion of our initial business combination or earlier upon redemption or our liquidation   VACHW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 5.07 Submission of Matters to a Vote of Security Holders.

     

    On March 12, 2026, Voyager Acquisition Corp., a Cayman Islands exempted company (“SPAC”) held an extraordinary general meeting of shareholders (the “Meeting”), at which holders of 21,743,532 SPAC Class A ordinary shares, par value $0.0001 per share (“SPAC Class A Ordinary Shares”) and SPAC Class B ordinary shares, par value $0.0001 per share (“SPAC Class B Ordinary Shares” and, collectively with the SPAC Class A Ordinary Shares, the “Shares”), were present in person or by proxy, representing approximately 68.754% of the voting power of the 31,625,000 issued and outstanding Shares entitled to vote at the Meeting as of the close of business on February 13, 2026, which was the record date for the Meeting.

     

    At the Meeting, SPAC shareholders approved a proposal to approve by ordinary resolution and adopt the Business Combination Agreement, dated as of April 22, 2025, by and among SPAC, Veraxa Biotech AG (the “Company”), a public limited company organized under the laws of Switzerland, and Oliver Baumann, solely in his capacity as shareholder representative, as amended on October 18, 2025 and as further amended on February 2, 2026 (the “Business Combination Agreement”), and the transactions contemplated therein (the “Business Combination”), pursuant to which (i) Voyager Acquisition Sponsor Holdco LLC (the “Sponsor”) formed Veraxa Biotech Holding AG (“PubCo”), (ii) PubCo formed an exempted company limited by shares incorporated under the laws of the Cayman Islands, to be a direct wholly owned subsidiary of PubCo (“Merger Sub”), (iii) Sponsor shall transfer the PubCo ordinary shares, par value CHF 1/113.25 per share (the “PubCo Ordinary Shares”) to the Contribution Agent, (iv) SPAC shall merge with and into Merger Sub, with Merger Sub as the surviving company in the merger and, after giving effect to clause (v), continuing as a wholly owned subsidiary of PubCo (the “Initial Merger”), (v) the Contribution Agent shall contribute the Merger Sub shares received in the Initial Merger on behalf of the SPAC shareholders to PubCo and an increase to capital contribution reserves, (vi) the Contribution Agent shall transfer the PubCo Ordinary Shares received by Sponsor to the SPAC shareholders, (vii) Merger Sub will distribute its assets to PubCo as a liquidating distribution and, as soon as reasonably possible, Merger Sub shall be dissolved under the laws of the Cayman Islands and will cease to be a wholly owned subsidiary of PubCo, and (viii) as soon as practicable, but not less than twenty-four hours following the completion of the Initial Merger, the Company will merge with and into PubCo, with PubCo as the surviving entity in the merger (the “Business Combination Proposal”).

     

    The following is a tabulation of the votes with respect to the Business Combination Proposal, which was approved by SPAC’s shareholders:

     

    Share Votes For   Share Votes Against   Share Abstentions
    20,453,587   1,289,900   45

     

    At the Meeting, SPAC shareholders also approved a proposal to approve by special resolution the Initial Merger and plan of initial merger (the “Initial Merger Proposal”).

     

    The following is a tabulation of the votes with respect to the Initial Merger Proposal, which was approved by SPAC’s shareholders:

     

    Share Votes For   Share Votes Against   Share Abstentions
    20,453,586   1,289,901   45

     

    At the Meeting, SPAC shareholders also approved a proposal to consider and vote to approve by special resolution, an amendment to the SPAC amended and restated memorandum of association to remove the limitation that prevents the SPAC from redeeming SPAC Shares sold as part of SPAC’s initial public offering if such redemption would cause the SPAC to have net tangible assets of less than $5,000,001 (the “NTA Amendment Proposal”).

     

    1

     

     

    The following is a tabulation of the votes with respect to the NTA Amendment Proposal, which was approved by SPAC’s shareholders:

     

    Share Votes For   Share Votes Against   Share Abstentions
    20,453,587   1,289,900   45

     

    At the Meeting, SPAC shareholders also approved four separate proposals to approve, on a non-binding advisory basis, certain governance provisions in the articles of association of PubCo (the “PubCo Charter”) upon completion of the Business Combination, specifically:

     

    To consider and vote for the governance provision in the PubCo Charter providing authorized share capital of PubCo to be CHF 1,247,904 divided into 141,325,128 PubCo Ordinary Shares and authorizes the issuance of conditional share capital up to 40,948,029 PubCo Ordinary Shares, which, the board of directors of PubCo is authorized to increase the share capital at any time until December 31, 2030 up to a maximum of 70,662,564 additional PubCo Ordinary Shares, the votes were as follows:

     

    Share Votes For   Share Votes Against   Share Abstentions
    20,453,586   1,289,901   45

     

    To consider and vote for the governance provision in the PubCo Charter providing for PubCo to have only one class of common shares, the votes were as follows:

     

    Share Votes For   Share Votes Against   Share Abstentions
    20,453,587   1,289,900   45

     

    To consider and vote for the governance provision in the PubCo Charter removing any blank check company provisions, the votes were as follows:

     

    Share Votes For   Share Votes Against   Share Abstentions
    20,453,586   1,289,901   45

     

    To consider and vote for the governance provision in the PubCo Charter providing that directors may only be removed by an absolute majority of the PubCo shareholders represented at a meeting of shareholders, the votes were as follows:

     

    Share Votes For   Share Votes Against   Share Abstentions
    20,453,587   1,289,900   45

     

    At the Meeting, SPAC shareholders also approved a proposal to consider and vote upon a proposal to approve the adjournment of the Meeting to a later date or dates in the event that there are insufficient votes for, or otherwise in connection with, the approval of one or more proposals (the “Adjournment Proposal”).

     

    The following is a tabulation of the votes with respect to the Adjournment Proposal, which was approved by SPAC’s shareholders:

     

    Share Votes For   Share Votes Against   Share Abstentions
    20,442,812   1,300,675   45

     

    2

     

     

    Item 7.01 Regulation FD Disclosure.

     

    On March 13, 2026, SPAC issued a press release (the “Press Release”) disclosing the number of redemptions which occurred in connection with the Meeting. For more information, please see Item 8.01 below. A copy of the Press Release is attached as Exhibit 99.1 and is incorporated herein by reference.

     

    The information under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into the filings of SPAC under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

     

    Item 8.01 Other Events.

     

    Redemptions

     

    In connection with the Meeting, SPAC shareholders holding an aggregate of 25,217,315 SPAC Class A Ordinary Shares exercised their right to redeem such shares for a pro rata portion of the funds in the trust account. As a result, approximately $885,556 will remain in SPAC’s trust account, subject to further redemption reversal requests (if any) received and approved by SPAC prior to the closing.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    The following exhibit is attached to this Current Report on Form 8-K:

     

    Exhibit No.   Exhibit Title or Description
    99.1   Press Release dated March 13, 2026.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    3

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      VOYAGER ACQUISITION CORP.
       
    Dated: March 18, 2026 By: /s/ Adeel Rouf
      Name: Adeel Rouf
      Title: President and Chief Executive Officer

     

    4

    Get the next $VACH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VACH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VACH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG

    BROOKLYN, N.Y., March 13, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: "VACHU," "VACH," "VACHW") ("Voyager" or the "Company") held the general meeting on March 12, 2026 and approved the previously announced business combination (the "Business Combination") with VERAXA Biotech AG ("VERAXA"). After the closing of the Business Combination, it is expected that the combined company will trade on Nasdaq under the new symbol ("VRXA"). As previously announced, holders of 25,217,315 of the Company's Class A ordinary shares ("Class A shares") exercised their right to redeem their shares for a pro rata portion of the funds in the Company's trust account, reflecting redemptions of

    3/13/26 6:00:00 AM ET
    $VACH

    Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG

    BROOKLYN, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: "VACHU," "VACH," "VACHW") ("Voyager" or the "Company") today announced that holders of 25,217,315 of the Company's Class A ordinary shares ("Class A shares") exercised their right to redeem their shares for a pro rata portion of the funds in the Company's trust account, reflecting redemptions of approximately 99.67% of the total Class A shares outstanding in connection with the completion of the Company's business combination (the "Business Combination") pursuant to the business combination agreement between the Company, VERAXA Biotech AG ("VERAXA") and the other parties thereto (the "Business Combi

    3/11/26 6:00:00 AM ET
    $VACH

    VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp.

    ZURICH, SWITZERLAND – March 2, 2026 -- VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies, today announced that its shareholders approved the merger between VERAXA and Veraxa Biotech Holding AG and the issuance of new shares of the combined company at the Extraordinary General Meeting ("EGM") on February 27, 2026. Both resolutions are prerequisites for the closing of the proposed business combination (the "Business Combination") among VERAXA, Veraxa Biotech Holding AG and Voyager Acquisition Corp. (NASDAQ:VACH, "Voyager"), "Voyager"), a special purpose acquisition company sponsored by Cantor Fitzgerald & Co., Voyager Acquisition Sponsor Holdco LLC, and Odeon

    3/2/26 1:00:00 AM ET
    $VACH

    $VACH
    SEC Filings

    View All

    SEC Form 425 filed by Voyager Acquisition Corp

    425 - Voyager Acquisition Corp./Cayman Islands (0002006815) (Subject)

    3/18/26 4:05:22 PM ET
    $VACH

    Voyager Acquisition Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Voyager Acquisition Corp./Cayman Islands (0002006815) (Filer)

    3/18/26 4:05:14 PM ET
    $VACH

    SEC Form 425 filed by Voyager Acquisition Corp

    425 - Voyager Acquisition Corp./Cayman Islands (0002006815) (Subject)

    3/11/26 8:44:20 PM ET
    $VACH

    $VACH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Voyager Acquisition Corp

    SC 13G - Voyager Acquisition Corp./Cayman Islands (0002006815) (Subject)

    11/14/24 5:32:56 PM ET
    $VACH

    SEC Form SC 13G filed by Voyager Acquisition Corp

    SC 13G - Voyager Acquisition Corp./Cayman Islands (0002006815) (Subject)

    11/14/24 1:17:46 PM ET
    $VACH

    Amendment: SEC Form SC 13G/A filed by Voyager Acquisition Corp

    SC 13G/A - Voyager Acquisition Corp./Cayman Islands (0002006815) (Subject)

    11/6/24 3:00:45 PM ET
    $VACH